Of possible interest

Recent blogs about the World Intellectual Property Organization (WIPO) meetings are available at http://keionline.org/wipo.

The US Secretary General High Level Panel on Access to Medicine. KEI submissions.

Request to NIH and Army to use government royalty free or march-in rights in the prostate cancer drug Xtandi.

Proposal for a WTO Agreement on the Supply of Public Goods.

Prices and patents on drugs, vaccines and diagnosis of hepatitis.

Innovation inducement prizes, possibly as an alternative to IPR monopolies to reward successful innovation.

Now is a good time to donate money to KEI

KEI Timelines, on a variety of topics.


Governments can ration access to cancer drugs, or break patent monopolies. Why is rationing so popular?:

Federal Circuit decision in AMP v. USPTO results in three-way split in reasoning; 2-1 decision finds isolated DNA patentable

It has been estimated that 1 out of every 8 women in the United States will develop invasive breast cancer during her lifetime. Although a diagnostic test exists to identify mutations on the BRCA1 and BRCA2 human genes, two genes associated with breast and ovarian cancer, many women are not afforded the opportunity to have testing done because Myriad Genetics holds exclusive rights over these genes.

WIPO General Assembly: Expectations loom over decisions on treaties for actors, reading disabled persons and genetic resources

The WIPO General Assembly meets from Monday, 26 September 2011 to Wednesday, 5 October 2011 and will take place at the International Conference Center Geneva (CICG), 17 rue de Varembé, 1211, Geneva.

The tentative schedule for 49th session of the WIPO General Assembly can be found here: http://www.wipo.int/edocs/mdocs/govbody/en/a_49/a_49_1_prov_2.pdf.

Medicines Patent Pool agreement with Gilead contains flexibilities including termination provisions and severability of licenses

On 12 July 2011, the Medicines Patent Pool (MPP) and Gilead announced an agreement for Gilead to license patents for tenofovir (TDF), emtricitabine (FTC), elvitegravir (EVG), cobisistat (COBI) and a four drug combination of these drugs. KEI's initial comments on the agreement are available here.

Decision for WIPO GA 49: Matters Concerning the IGC on IP and genetic resources, traditional knowledge and folklore

After ten years of deliberations, the 19th session (18-22 July 2011) of the WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC/GRTKF) submitted a Decision for approval to the WIPO General Assembly (26 September-5 October 2011) that could pave the way for the General Assembly in 2012 to convene a Diplomatic Conference on an international legal instrument(s) for the protection of genetic resources, traditional knowledge and traditional cultural expressions (TCEs).

OMPI: Un instrument international pour la protection des ressources génétiques, des savoirs traditionnels et du folklore?

L’OMPI sur la voie d’un instrument international pour la protection des ressources génétiques, des savoirs traditionnels et du folklore.


Eugenia Olliaro (KEI)

Of WIPO, diplomatic conferences and international legally binding instruments

The 19th session of the WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore is meeting this week in Geneva (18-22 July 2011) to make a a decision on a possible international legal instrument (or instruments) to protect genetic resources, traditional knowledge and folklore. At the discussions of future work on 19 July 2011, the United States (Albert Tramposch, USPTO) asked the WIPO Legal Counsel (Edward Kwakwa) the following question.

Like-Minded Group requests convening of WIPO Diplomatic Conference on genetic resources, traditional knowledge and folklore

From 27 June to 30 June 2011, representatives from the like minded group of countries including Algeria, Angola, Bangladesh, Colombia, Egypt, India, Indonesia, Malaysia, Myanmar, Namibia, Pakistan, Peru, South Africa, Tanzania, Thailand, and Zimbabwe met in Bali, Indonesia to discuss the protection of genetic resources, traditional knowledge and folklore. This group submitted a joint recommendation to the WIPO secretariat (WIPO/GRTKF/IC/19/8) requesting the following:

KEI, MSF, Oxfam and PC provide follow up comments on USPTO humanitarian priority review voucher proposal

USPTO is currently considering a pilot program to grant priority review vouchers as an incentive mechanism for technologies or licensing that responds to humanitarian needs. KEI, MSF, Oxfam and PC previously submitted comments on November 19, 2010 and provided additional comments on March 4, 2011 with UAEM.

2nd meeting of WHO Consultative Working Group on R&D Financing (CEWG): Summary of proceeedings by Chair (John Arne Røttingen)

On 8 July 2011, the WHO Consultative Expert Working Group on R&D Financing and Coordination (CEWG) held an open session to brief the public on their preliminary assessments and recommendations.

To access the slide presentation presented by the Chair (John Arne Røttingen, Norway) and Vice-Chair (Claudia Inês Chamas, Brazil), please click on the following link: http://www.who.int/phi/news/Open_Session_July_v3.pdf

KEI comment on the Medicines Patent Pool license with Gilead

KEI comment on the Medicines Patent Pool license with Gilead
July 12, 2011

FYI: James Love (Tuesday: +44.785.543.6510, james.love@keionline.org). Thiru Balasubramaniam (thiru@keionline.org) or Krista Cox (krista.cox@keionline.org, +1.202.332.2670).

BRICS Health Ministers’ Meeting-Beijing Declaration

BRICS Health Ministers’ Meeting
Beijing Declaration
July 11, 2011

KEI/South Centre panel on Doha+10: The State of Implementation, 14 November 2011

Doha +10

On 14 November 2001, at its Ministerial in Doha, Qatar, the World Trade Organization (WTO) adopted the Doha Declaration on the TRIPS Agreement and public health. Exactly 10 years to the date, Knowledge Ecology International (KEI) and the South Centre have are co-hosting a side event at WIPO to discuss the following questions:

How have WTO members implemented paragraphs 4, 6 and 7 of the Doha Declaration? What changes are needed to achieve access to medicine for all?

WIPO patent committee solicits comments on proposals on quality of patents (including opposition systems) and patents and health

On 28 June 2011, Francis Gurry, Director General of the World Intellectual Property Organization (WIPO), sent out Circular note 7998 requesting Member States and Observers to the WIPO Standing Committee on the Law of Patents (SCP) to submit comments on the the proposal by Canada and the United Kingdom of Great Britain and Northern Ireland on Quality of Patents, including Opposition Systems and the proposal by South Africa on behalf of the African Group and the Development Group on

USTR New Exclusive Right for Copyright Holders: Importation Provision in the Trans Pacific Partnership Agreement (TPPA)

At the recently completed Vietnam round of negotiations for the Trans-Pacific Partnership Agreement (TPPA), once again, no official text of negotiation was released. Therefore, we still need to speculate about its status, relying in part on a three-month-ago leaked version of the intellectual property chapter proposed by the Office of the United States Trade Representative (USTR).

WHO mission briefing on reform: State of play on World Health Forum, Independent Evaluation and Governance

On 1 July 2011, the World Health Organization (WHO) convened a Mission Briefing in Geneva for WHO delegates to discuss WHO reform.

Syndicate content